Cargando…
Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study
INTRODUCTION: We aimed to evaluate prognostic factors of a second allogeneic stem cell transplantation (allo-HSCT2) among hematological malignancy patients who have relapsed after the first allo-HSCT(allo-HSCT1). METHODS: We retrospectively analyzed 199 hematological malignancy patients who received...
Autores principales: | Lu, Yue, Zhang, Jian-Ping, Zhao, Yan-Li, Xiong, Min, Sun, Rui-Juan, Cao, Xing-Yu, Wei, Zhi-Jie, Zhou, Jia-Rui, Liu, De-Yan, Yang, Jun-Fang, Zhang, Xian, Lu, Dao-Pei, Lu, Peihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846785/ https://www.ncbi.nlm.nih.gov/pubmed/36685540 http://dx.doi.org/10.3389/fimmu.2022.1066748 |
Ejemplares similares
-
Advances in Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia
por: Nannya, Yasuhito, et al.
Publicado: (2022) -
Allogeneic hematopoietic stem cell transplantation for non-malignant hematological disorders
por: Mahmoud, Hossam K., et al.
Publicado: (2015) -
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies
por: Zahid, Mohammad Faizan, et al.
Publicado: (2014) -
Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia
por: Zhao, Yan-Li, et al.
Publicado: (2021) -
Allogeneic hematopoietic stem-cell transplantation for
myelofibrosis
por: Zhang, Lining, et al.
Publicado: (2020)